You are on page 1of 2

Week 4 | Drug Therapy for Seizure, Thyroid, Adrenal Gland Problems

Case Study (1)

Week 4: Drug Therapy for Seizures

------------------------------------------------------------------------------------------------------------
Ms. Peterson, aged 48 years, is admitted to the hospital with a seizure disorder. She
experiences generalized seizures approximately once a month. Her prescribed drugs
include carbamazepine (Tegretol) 300 mg three times a day. Carbamazepine comes in
100-mg tablets. The patient states that while taking this drug she sometimes experiences
nausea and vomiting as well as dizziness.
------------------------------------------------------------------------------------------------------------

1. What important teaching points will you share with the patient about this drug?

2. What safety measures will you take when admitting Ms. Peterson to your hospital unit?

BSN210 Clinical Pharmacology Dr. Mahmoud Al-Qadi


Week 4 | Drug Therapy for Seizure, Thyroid, Adrenal Gland Problems

Case Study (2)

Week 4: Drug Therapy for Thyroid and Adrenal Gland Problems

------------------------------------------------------------------------------------------------------------
The patient is a 43-year-old woman who is scheduled to have a hysterectomy later today.
During her preadmission testing, her vital signs are T = 37.8, P = 88 with several
“skipped” beats, R = 20, BP = 160/148. She is 5'6" and weighs 50 kg. Her current drugs
are metoprolol (Toprol 50 mg) for hypertension, levothyroxine (Synthroid) 200 mcg
daily, and aspirin 81 mg daily. When you ask her about her hypertension, she shouts that
her blood pressure problem is being managed and that you should focus on her
impending surgery. Then she apologizes for her behavior and says that she has not been
sleeping well lately, probably because of worrying about the scheduled surgery.
------------------------------------------------------------------------------------------------------------

1. What type of drug is levothyroxine?

2. What are the side effects of this drug?

3. Which, if any, vital sign abnormalities, patient-reported signs or symptoms, and


observed physical attributes and behavior(s) could be attributed to this drug? Provide
rationales for your selections.

BSN210 Clinical Pharmacology Dr. Mahmoud Al-Qadi

You might also like